The low expression of phosphatase and tensin homolog (PTEN) is attributed to the activation of the PI3K/AKT signaling pathway, a phenomenon that leads to tumor progress, drug resistance, epithelial–mesenchymal transition (EMT), as well as neoangiogenesis [95,96]. The gene discussed is AKT1; the disease is neoplasm.